GeneTex
  • Country / Location Selection

United States (US)

HTATSF1 blocking peptide

Cat No. GTX88971-PEP

Application ELISA, Apuri, Blocking
Species Human
Package
100μg ($239)
APPLICATION

Application Note

*Optimal dilutions/concentrations should be determined by the researcher.
Application Dilution
ELISA Assay dependent
Apuri Assay dependent
Blocking Assay dependent
Not tested in other applications.

Specificity/Sensitivity

The peptide was used in the production of GTX88971.
PROPERTIES

Form

Lyophilized powder

Buffer

Lyophilized from 5% (v/v) acetonitrile/H₂O. Reconstitute pellet in 200μl distilled water to obtain a 0.5mg/ml peptide solution.

Storage

Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.

Region/Sequence

C-QELYGDGKDGDTQTD

Note

For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
TARGET

Synonyms

Hiv-1 Tat Specific Factor 1,Tat-Sf1,Tatsf1,Dj196E23.2,Htatsf1

Background

The protein encoded by this gene functions as a cofactor for the stimulation of transcriptional elongation by HIV-1 Tat, which binds to the HIV-1 promoter through Tat-TAR interaction. This protein may also serve as a dual-function factor to couple transcription and splicing and to facilitate their reciprocal activation. Alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Sep 2009]
REFERENCE
There are currently no references for HTATSF1 blocking peptide (GTX88971-PEP).
Be the first to share your publications with this product.
REVIEW
There are currently no reviews for HTATSF1 blocking peptide (GTX88971-PEP).
Be the first to share your experience with this product.
Package List Price ($)
$ 239